Free Trial
LON:MHC

MyHealthChecked (MHC) Share Price, News & Analysis

MyHealthChecked logo
GBX 11.28 -0.23 (-1.96%)
As of 11:39 AM Eastern

About MyHealthChecked Stock (LON:MHC)

Key Stats

Today's Range
11.28
11.50
50-Day Range
11
15.40
52-Week Range
8
21
Volume
6,944 shs
Average Volume
44,130 shs
Market Capitalization
£5.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests. MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Receive MHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MyHealthChecked and its competitors with MarketBeat's FREE daily newsletter.

MHC Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Oberon AIM VCT Ord (OVCT.L)
Returns At MyHealthChecked (LON:MHC) Are On The Way Up
See More Headlines

MHC Stock Analysis - Frequently Asked Questions

MyHealthChecked's stock was trading at GBX 12.50 at the beginning of 2025. Since then, MHC shares have decreased by 9.8% and is now trading at GBX 11.28.
View the best growth stocks for 2025 here
.

Shares of MHC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that MyHealthChecked investors own include Beowulf Mining (BEM), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Gresham House Strategic (GHS) and Greencore Group (GNC).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:MHC
CIK
N/A
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.04 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£9.43 million
Cash Flow
GBX 6.34 per share
Price / Cash Flow
1.78
Book Value
GBX 14.54 per share
Price / Book
0.78

Miscellaneous

Free Float
N/A
Market Cap
£5.87 million
Optionable
Not Optionable
Beta
1.37
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:MHC) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners